Of note, accumulating evidence indicates a tumor‐suppressive role for SHP‐1 and SHP‐2 and supports the use pharmacological strategies aimed at enhancing the activity of such tyrosine phosphatases in cancer cells (Fan et al., 2015; Huang et al., 2017; Qi et al., 2017). The gene discussed is PTPN11; the disease is cancer.